Abiopharma

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium

Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Sales and Reaffirms 2026 Revenue Guidance

Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs - and Why Molecule.ais Drug Discovery Platform Matters More Than Ever

Notification from BriaCell Therapeutics Corp.

Travere Therapeutics Announces FDA Extends Review of sNDA for FILSPARI® (sparsentan) in FSGS

Law Offices of Frank R. Cruz Encourages agilon health, inc. (AGL) Shareholders To Inquire About Securities Fraud Class Action

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial